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The GTF2IRD1 gene is of principal interest to the study of
Williams-Beuren syndrome (WBS). This neurodevelopmen-
tal disorder results from the hemizygous deletion of a region
of chromosome 7q11.23 containing 28 genes including
GTF2IRD1. WBS is thought to be caused by haploinsufficiency
of certain dosage-sensitive genes within the deleted region, and
the feature of supravalvular aortic stenosis (SVAS) has been
attributed to reduced elastin caused by deletion of ELN. Human
genetic mapping data have implicated two related genes
GTF2IRD1 and GTF2I in the cause of some the key features of
WBS, including craniofacial dysmorphology, hypersociability,
and visuospatial deficits. Mice with mutations of the Gtf2ird1
allele show evidence of craniofacial abnormalities and behav-
ioral changes. Here we show the existence of a negative autoreg-
ulatory mechanism that controls the level of GTF2IRD1 tran-
scription via direct binding of theGTF2IRD1 protein to a highly
conserved region of the GTF2IRD1 promoter containing an
array of three binding sites. The affinity for this protein-DNA
interaction is critically dependent upon multiple interactions
between separate domains of the protein and at least two of the
DNA binding sites. This autoregulatory mechanism leads to
dosage compensation of GTF2IRD1 transcription in WBS
patients. The GTF2IRD1 promoter represents the first estab-
lished in vivo gene target of theGTF2IRD1protein, andweuse it
to model its DNA interaction capabilities.
Williams-Beuren syndrome (WBS)4 is a relatively rare disor-
der with an estimated incidence of 1:7,500–1:20,000 (1). In 95%
of cases, this deletion is 1.5 Mb long and results from illegiti-
mate recombination during meiosis between two blocks of low
copy repeats (LCRs) that flank the deletion domain (2, 3). To
explain the causes of WBS in molecular terms, it is first neces-
sary to identify the genes that underpin each of the disorders.
The only symptom that fulfills this to date is SVAS. Haploin-
sufficiency of elastin due to loss of the ELN gene leads to nar-
rowing of the large elastic aorta and may also affect the pulmo-
nary, coronary, and carotid arteries (4). Accumulating evidence
from patients with atypical hemizygous deletions within the
critical region indicate that the many of the remaining symp-
toms, in particular the craniofacial abnormalities, the visuospa-
tial construction deficit and the hypersociability, can be attrib-
uted to two genes at the telomeric end of the deletion region,
GTF2IRD1 and GTF2I (5–7). These genes share sequence
homology and are adjacent, indicating that they have arisen by
duplication and divergence from a common ancestor. Func-
tional evidence suggests that these genes encode nuclear pro-
teins with DNA binding capabilities and are widely considered
to be transcription factors with specific gene targets (8, 9).
The first reported gene product of GTF2IRD1 was Mus-
TRD1, which was isolated in a yeast one-hybrid screen for pro-
teins that could bind to aDNA enhancer element present in the
TNNI1 gene (10). Human,mouse, andXenopus orthologs of the
gene were subsequently isolated in three independent yeast
one-hybrid screens as GTF3 (11), BEN (12), and XWBSCR11
(13). Herein, we will refer to protein and gene by the approved
symbol GTF2IRD1. A comparison of the bait sequences used in
each of the four yeast one-hybrid assays revealed a common
core binding sequence of GGATTA and subsequent DNA
binding studies confirmed this as the core recognition motif
(14–16). In the yeast one-hybrid studies, GTF2IRD1 protein
was implicated in the regulation of the genes from which each
of the baits were derived; TNNI1, Hoxc8, and GSC.
In this report, we explore an autoregulatory feedback circuit
that regulates the levels of GTF2IRD1 transcript. This mecha-
nism is responsible for an observed increase in the levels of
transcript produced from the targetedGtf2ird1 allele in knock-
out mice and leads to dosage compensation ofGTF2IRD1 tran-
script in cell lines derived from WBS patients. This calls into
question whether the GTF2IRD1 protein is haploinsufficient in
WBS. We demonstrate that this mechanism is controlled
directly by GTF2IRD1 binding to a highly conserved upstream
region of its own gene and show that the binding affinity is
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critically dependent upon multiple interactions of the repeat
domains with at least two binding sites. These data constitute
the first definitive example of an interaction between
GTF2IRD1 and a target gene, supportable by in vivo data, and
therefore serves as a valuable model system for the study of
GTF2IRD1 DNA binding.
EXPERIMENTAL PROCEDURES
Knock-out—ThemouseGtf2ird1 allele was targeted in 129R1
ES cells using homologous arms flanking exon 2 inserted into
the pPGKneobpALox2DTA plasmid. The neomycin cassette
was subsequently removed using cre/lox excision by mating to
C57BL/6JArc mice carrying the Tg(CMV-Cre)1Cgn transgene
(17). The mutant allele was backcrossed onto C57BL/6JArc,
and these experiments were conducted on the N5 generation.
Protein Expression Analysis—C2C12 cells were washed with
ice-cold phosphate-buffered saline, sonicated, and lysed in
RIPA buffer supplemented with protease inhibitor mixture
(Roche) for 30 min at 4 °C. Cell lysates were centrifuged at
13,000  g for 20 min to remove cell debris and precleared by
incubation with protein G-Sepharose beads (Roche) for 1 h at
4 °C. The anti-GTF2IRD1 antibody (WBSCR11 (M-19), cat. no.
sc-14714, Santa Cruz Biotechnology) was coupled to protein G
beads for 1 h at 4 °C. Pre-cleared lysates were incubated with
the antibody-bound beads at 4 °C overnight. For the peptide
block experiment, WBSCR11 (M-19) antigenic peptides were
added during antibody precoupling and during incubationwith
precleared lysates. Beads were washed in RIPA buffer three
times and proteins were eluted by boiling in 2 SDS sample
buffer. One-fifth of immunoprecipitated eluent was separated
by 6% SDS-polyacrylamide gels and analyzed by immunoblot-
ting with the anti-GTF2IRD1 antibody, WBSCR11 (M-19).
Wild-type and mutant cDNA fragments were amplified
from brown adipose tissue-derived cDNA samples using
mIRD1ex1F and mIRD1ex7/8R (see supplemental Table S2)
and inserted into a pre-existing pCDNA3.1 (Invitrogen)
expression plasmid containing mouse Gtf2ird1 isoform 37 to
recreate the full-length wild-type and mutant transcripts pres-
ent in the mice. These plasmids were transiently transfected
into COS-7 cells using Lipofectamine (Invitrogen). Protein
extracts were made with RIPA buffer using standard meth-
ods, electrophoresed on 7.5% SDS-polyacrylamide gels and
analyzed by immunoblotting with the anti-GTF2IRD1 anti-
bodies,WBSCR11 (M-19), cat. no. sc-14714 (Santa Cruz Bio-
technology) and G21, raised in sheep against the peptide
CNNAKVPAKDNIPKRK.
Cell Lines and Immunofluorescence—Lymphoblastoid cell
lines derived from sixWBS patients and six relatives were cho-
sen (Coriell Cell Repository; see supplemental Table S1). Cell
lines were maintained in RPMI 1640 (GIBCO) supplemented
with glutamine and 15% fetal calf serum according to Coriell
protocols.
Inducible C2C12 Myc-GTF2IRD1 (mouse isoform 37)
(18) clones were produced using the RheoSwitch system
(New England Biolabs). Parental C2C12 cells grown in low
glucose GlutaMAX DMEM (GIBCO) with 20% fetal calf
serum were transfected with pNEBR-R1 and neomycin-re-
sistant clones were tested for high expression of the
RheoActivator and RheoReceptor proteins. A high expressing
clone was transfected with the pNEBRX1-Hygro plasmid con-
taining a cDNA encoding N-terminal Myc-tagged mouse
GTF2IRD1 and hygromycin-resistant clones were screened for
inducible Myc-GTF2IRD1 expression.
Myc-GTF2IRD1 was identified by immunofluorescence
using cells grown on glass coverslips, fixed in 4% paraformalde-
hyde, 0.125% Triton, incubated with the anti-Myc 9E10 mono-
clonal antibody (Sigma), followed by goat anti-mouse Alexa
Fluor 488 (Molecular Probes Invitrogen) secondary antibody
and mounted in Vectashield (Vector Laboratories) containing
1.5 g/ml 4,6-diamidino-2-phenylindole (DAPI).
Six inducible cell cloneswere identified, and somemosaicism
of inducible expression was apparent in all. Silencing of expres-
sionwas observed to increase rapidlywith passage number. The
line expressing the most in the greatest number of cells was
used for subsequent transfection assays.
RNA Expression Analysis—Mouse tissues were dissected and
stored in RNAlater (Ambion). Cell lines were washed with
phosphate-buffered saline and homogenized in TriReagent
(Sigma) by trituration. RNA was isolated according to the
TriReagent instructions. First-strand cDNA synthesis was per-
formed using 1 g of total RNA, M-MLV reverse transcriptase
(Promega), and oligo (dT)15 primers (Promega).
RNA was electrophoresed in MOPS/formaldehyde gels and
blotted according to standard methods (Hybond, GE Health-
care). Membranes were hybridized with a 32P-labeled probe
derived from the full-length mouse Gtf2ird1 cDNA (isoform
mouse 37) at 65 °C according to standard protocols (19).
Quantitative PCR was performed in a Corbett Rotor-Gene
2000 using the QuantiTect SYBR green PCR kit (Qiagen). Each
measurementwasmade in duplicate using 5l of diluted cDNA
template. Primer sequences are shown in supplemental Table
S2. For the human lymphoblastoid cell lines, measurements
weremade in duplicate fromRNAcollected on 3 separate occa-
sions and normalized to GAPDH measurements made in the
same way. This was done to minimize errors associated with
cell culture conditions.
Electrophoretic Mobility Shift Assay (EMSA)—Human
GTF2IRD1, GTF2IRD1LZ (lacking the first 81 amino acids at
the N terminus, see supplemental Table S2), mouse GTF2IRD1
isoforms 35 and 37 and themouse GTF2I (TFII-I)  isoform
were produced by in vitro coupled transcription-translation
using T7-primed TNT rabbit reticulocyte lysate (Promega) and
1 g of pCDNA3.1 plasmid (Invitrogen) containing the cDNA
of interest. Labeled probes were made in two ways. For the B1
combinations, complementary oligonucleotides were synthe-
sized with an AGCT 5-overhang at both ends, which were
filled in using the DECAprimeII 5x-dCTP reaction buffer and
Exo- Klenow enzyme (Ambion) in the presence of [32P]dCTP.
For thewild-typemouseGUR fragment and the variousmutant
forms, double-stranded DNA fragments were generated by
PCRusingGURprimers (see supplemental Table S2). The tem-
plate was derived from C57BL/6 mouse genomic DNA and the
template for fragments containing the middle mutation was
synthesized as a single stranded oligonucleotide (GUR MID
MUT, mouse). All fragments were labeled by incubation of the
denatured DNA with DECAprimeII 5-dCTP reaction buffer,
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Exo- Klenow enzyme (Ambion) and [32P]dCTP in the presence
of the same primers used to amplify the fragment initially.
Unincorporated nucleotides were removed using G-25 spin
column (GE Healthcare). DNA binding reactions and gel run-
ning conditions were as described previously (10).
Bioinformatics—genome sequences of human,mouse,Xeno-
pus tropicalis, and Takifugu rubripes were obtained from the
Ensembl genome server. EST sequences for mouse and human
were derived from theNCBI data base and theX. tropicalis EST
from theX. tropicalis project at the Sanger CentreUK. ESTs for
fugu or any other fish species do not include entries that show
exon 1 of the GTF2IRD1 gene. Therefore, exon 1 and the asso-
ciated GUR were manually curated using a combination of
homology searches between T. rubripes and Tetraodon nigro-
viridis genomic sequences derived from the Ensembl data base
and the use of the GENSCAN server at MIT. BLAST align-
ments were performed using the bl2seq alignment tool avail-
able at NCBI with genomic sequence from the various species
spanning the whole gene plus 10-kb upstream.
RESULTS
To determine the function of Gtf2ird1 and to examine its
potential role in WBS, we created a mouse knock-out (KO) by
targeted deletion of exon 2 (Fig. 1A), which contains the start
codon. Homozygous Gtf2ird1tm1Hrd mice have no obvious
developmental defects, but show specific behavioral changes, a
motor coordination deficit and evidence of altered GABAergic
neuronal function.5
Analysis of Transcription and Translation in Gtf2ird1tm1Hrd
Mice—An initial examination of Gtf2ird1 expression in tissues
from KOmice suggested that a mutant transcript lacking exon
2 is produced from the targeted allele. Because exon 2 and its
splice junctions were removed entirely, we predicted that exon
1 was splicing directly to exon 3. To test the efficiency of this
process, we examined the activity ofGtf2ird1 in brown adipose
tissue, which we have established previously as one of the
highest Gtf2ird1-expressing tissues in the adult mouse (20).
RNA was extracted from adult littermates segregating the
Gtf2ird1tm1Hrd allele, and RTPCRwas conducted using primers
that bind to sequences in exon 1 and exon 3 to determine the
relative proportions of wild-type and mutant transcript (Fig.
1B). In heterozygous KO mice, the level of mutant transcript
was deemed to be approximately equal to the level of transcript
produced from the wild-type allele.
The first downstream AUG in the mutant transcript resides
in exon 3 and is out of frame. The AUG in this reading frame is
followed 5 codons later by a premature termination codon. The
mutant transcript is clearly not subject to nonsense-mediated
decay (NMD) as shown above (Fig. 1B), which is probably
because of the close proximity of the start codon to the prema-
ture termination codon. Short nonsense open reading frames
can escape NMD as seen in mutants of the -globin gene (21).
Translation of an in-frame-truncated GTF2IRD1 peptide
could result from translational re-initiation beginning at the second AUG at residue Met-65, also located in exon 3. Detec-
tion of endogenous GTF2IRD1 protein is extremely difficult,
probably because of a very low general abundance, but is possi-
ble by immunoprecipitation in C2C12 cells, which are known
to express high levels of Gtf2ird1 transcript (Fig. 1C). How-
5 M. Howard, E. Tay, S. Palmer, J. Widagdo, J. Hook, F. Lemckert, K. Popovic, P.
Gunning, M. Spitzer, M. Murphy, A. Hannan, and E. Hardeman, submitted
for publication.
FIGURE 1. Generation of the Gtf2ird1tm1Hrd mutant allele and the conse-
quences for transcription and translation. A, homologous recombination
of the targeting construct with the wild-type (WT) allele using positive neo-
mycin (Neo) selection and negative diphtheria toxin (DTA) selection. The Neo
cassette was subsequently removed using the flanking LoxP sites (arrow-
heads). B, RTPCR analysis of Gtf2ird1 transcripts in brown adipose tissue from
a litter ofmice segregating themutant allele usingprimers in exon1andexon
3 (shown in scheme). Anovel exon1–3 splice transcript is producedwithequal
efficiency to thewild-type transcript. C, Western blot of proteins immunopre-
cipitated (IP) from C2C12 cell extracts using the M19 antibody for IP and as
probe. The immunoprecipitation was conducted in the presence () or
absence () of a blockingpeptide antigen todemonstrate specificity.D, anal-
ysis of transcription and translation from a wild-type Gtf2ird1 cDNA and the
equivalentmutant cDNA lackingexon2. Extracts from transfectedCOS-7 cells
show that both transcripts are abundantly produced (Northern Gtf2ird1) but
the GTF2IRD1 peptide is below detectable levels in cells expressing the
mutant transcript (KO) using two antibodies, M19 and G21. Equal loading is
shown by ethidium bromide staining of RNA and Coomassie Blue staining of
protein in the M19 Western blot. E, Western blot analysis using sequential
dilutionsofprotein extract fromcells transfectedwith thewild-type construct
compared with high concentration loadings of mutant extract (KO), probed
with M19 and G21 antibodies. A faint band is visible at the highest concen-
tration in the M19 analysis (arrowhead). Numbers represent g of total
protein.
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ever, measuring reduced endogenous levels of any potential
translational re-initiation products is harder still and well
below the possible limits of detection. Therefore, a mutant
cDNA representative of a transcript from the KO allele (cor-
responding to the full-length mouse 37 isoform (18) but
lacking exon 2), was cloned into an expression vector and
transfected into COS-7 cells. Transcription from this
mutant cDNA was comparable to the wild-type 37 control;
although2-fold lower (Fig. 1D). By loading a large amount
of protein extract (150 g) from cells transfected with the
mutant construct, a faint band corresponding to a truncated
GTF2IRD1 peptide could be detected using the anti-
GTF2IRD1, WBSCR11 (M-19) antibody (Fig. 1E). A similar
analysis using the G21 antibody was unable to detect any
mutant protein, even at the high-
est concentrations (Fig. 1E). By
comparison with dilutions of the
extracts derived from the wild-
type transfections and taking into
account the relative levels of
Gtf2ird1 and Gtf2ird1tm1Hrd tran-
script (measured by quantitative
RTPCR); it was possible to esti-
mate that the efficiency of produc-
tion of the mutant peptide is 3%
of normal levels.
Negative Autoregulation Controls
GTF2IRD1 Transcription in Mice
and Humans—Initial examination
of the mutant transcript in the
Gtf2ird1tm1Hrd KO mice suggested
that levels were higher than nor-
mal. To examine this in detail, we
used RNA extracted from a num-
ber of tissues and performed
Northern blotting (Fig. 2A) and
quantitative RTPCR (Fig. 2B)
using primers that amplify mutant
and wild-type transcript indiscrim-
inately (mIRD1ex6F- mIRD1ex7/
8R). Total levels of Gtf2ird1 tran-
script were significantly higher in
heterozygous and homozygous
Gtf2ird1tm1Hrd KOs, with levels in
the homozygous nulls approxi-
mately double the normal level of
transcript (Fig. 2B). This result con-
curred with the band intensities
seen in Northern blots of RNA
extracted from a number of repre-
sentative mice (Fig. 2A). The most
plausible explanation for these find-
ings was the existence of a negative
feedback mechanism that increased
Gtf2ird1 transcription in response
to the depletion of GTF2IRD1
protein.
We reasoned that if such a nega-
tive autoregulatory mechanism were conserved in humans,
WBS patients, who only have one allele of GTF2IRD1, might
undergo a formof dosage compensation and restoreGTF2IRD1
transcript levels to normal. We examined the expression of
GTF2IRD1 and its flanking genes in lymphoblastoid cell lines
derived from sixWBS patients and six relatives using quantita-
tive RTPCR (Fig. 3) with primers designed within the coding
regions. The mean expression levels of the flanking genes
CYLN2 andGTF2Iwere just above the expected 50% of normal.
However, mean levels of GTF2IRD1, although slightly lower
than normal (92%), were not significantly different from levels
in their unaffected relatives (Fig. 3). This result was confirmed
using a separate RTPCR assay (see supplemental Fig. S1) using
primers designed to amplify a different portion of the
FIGURE 2. Gtf2ird1 transcript production approximately doubles in the tissues of Gtf2ird1tm1Hrd knock-
outmice. A, Northern blot of total RNA extracted from brown adipose and brain tissue of three wild-type and
threehomozygous knock-outmice showing that the3.5-kbGtf2ird1band ismore intense in all three knock-out
mice. Close scrutiny also shows an expected slight reduction in transcript length because of the loss of exon 2
(129 bp) in the knock-out samples. B, quantitative RT-PCR analysis of Gtf2ird1 levels. Error bars show S.D., and
the numbers indicate the number of mice used. Unpaired two-tailed Student’s t tests show a difference
between wild-type (WT/WT) and homozygous null (KO/KO) genotypes with a probability of: p  0.0011 for
brown adipose, p 0.012 for brain, p 0.0019 for heart, and p 0.022 for spleen.
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GTF2IRD1 cDNA. GTF2IRD1 transcript levels were highly
variable between individuals of all genotypes, suggesting that
this is typical behavior, at least in this cell type, and is not asso-
ciated with the WBS condition.
The GTF2IRD1 Gene Contains a Conserved GTF2IRD1 DNA
Binding Domain—Because GTF2IRD1 protein binds DNA in a
sequence-specific manner (14–16), we reasoned that the nega-
tive autoregulatory mechanismmight involve direct binding of
GTF2IRD1 protein to an enhancer element within the
GTF2IRD1 allele.On the assumption that such a binding region
would be conserved, we conducted phylogenetic footprinting
analysis using the genome sequence of GTF2IRD1 genes from
human, mouse, chicken, zebrafish, X. tropicalis, and T. ru-
bripes.Within non-transcribed domains, a region immediately
adjacent to the transcription start site in mouse and human
emerged as a clear candidate for this hypothesis. The
GTF2IRD1 upstream region (GUR), which we have defined as a
104-bp region of high homology, shows 82% sequence identity
between human and fish species. Significantly, the GUR con-
tains three canonicalGTF2IRD1 recognition sequences (Fig. 4).
Assuming equal and random base distributions, the incidence
of the sequence GGATTA or the inverted TAATCC, should
occur by chance every 512 bp. Within the 150 kb of DNA con-
taining the human GTF2IRD1 gene, the observed mean fre-
quency is 549 bp. It is unlikely, therefore, that these three sites
are present within 104 bp by chance.
It is interesting to note that the GGATTA sites themselves
show 100% identity between all of the species, and the sequence
homology ends abruptly either side of the proximal and distal
GGATTA sites. Apart from the conjunction of these 3 sites, the
region is relatively unremarkable. It does not contain a conven-
tional TATA box but does have a well-conserved CCAAT box
and potential elements that match a number of known tran-
scription factor recognition sequences, but their significance is,
so far, unknown.
FIGURE 3. Quantitative RT-PCR analysis of CYLN2, GTF2I, and GTF2IRD1
expression in lymphoblastoid cell lines derived from Williams-Beuren
syndrome patients and their relatives. Error bars show S.D., and the figure
in the patient bar indicates the estimatedmean expression level as a percent-
age of the relatives’ mean. Paired two-tailed Student’s t tests show differ-
ences between the means of genotype groups with a probability of: CYLN2
p 0.004575, GTF2I p 0.000342, and GTF2IRD1 p 0.559668.
FIGURE4.ClustalWalignmentof theGUR in four vertebrate species.Colored boxes indicate identical base residues, and thearrows indicate theposition and
orientation of three highly conserved GTF2IRD1 recognition sequences. The core motifs are perfectly conserved, but conservation quickly diminishes either
side of the flanking sites. The transition to bold lowercase indicates the start of themost 5 ESTs found in data base searches. Human EST BM544769,Mouse EST
CJ178886, X. tropicalis EST CN092749. No informative Fugu ESTs were found.
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GTF2IRD1 Binding to the GUR Requires a Tandem Interac-
tion—The cluster of well-conserved GGATTA binding sites
indicates a strong potential for interaction with the GTF2IRD1
protein. Furthermore, the presence of three sitesmight indicate
that the protein has a preference for multiple binding sites.
Therefore, we tested the relative affinity of GTF2IRD1 for mul-
tipleGGATTAbinding sites in an EMSAusing artificial trimer-
ic and dimeric DNA probes based on the sequence used in the
TNNI1 yeast one-hybrid screen originally used to isolate
GTF2IRD1 (10). The affinity of in vitro translated GTF2IRD1
for a single GGATTAwas below the level of detection (Fig. 5A).
However, with two sites the interaction was strong, and with
three sites band intensity increased further and a second higher
shift complex (HC) became visible.
The GUR of themouse was amplified from genomic DNA by
PCR and labeled for EMSA analysis. Mouse and human
GTF2IRD1 isoforms bound with high affinity to the GUR
probe, whereas the related GTF2I (TFII-I) peptide encoded by
Gtf2i did not (Fig. 5B). Human GTF2IRD1 formed a lower shift
complex (LC) and a higher shift complex (HC) with the GUR
probe.On the assumption that theHCmay be caused by dimer-
ization of GTF2IRD1, which is reportedly mediated via the
leucine zipper (LZ) (15), we made an N-terminal deletion of
human GTF2IRD1 that lacks the LZ motif and found that this
peptide fails to form the HC shift, whereas the intensity of the
LC is significantly enhanced (Fig. 5C).
To determine whether binding is dependent on the presence
of all three GGATTA recognition sequences, we prepared a
series of DNA probes with 3-bp mutations within the core
motif, changing GGATTA into GGTCAA, either singly or in
combination (Fig. 5, D–F). Mutation of the distal site does not
impact significantly on the LC, but the HC becomes very weak;
whereas, mutation of the proximal site reduces binding of both.
When both flanking sites are mutated, binding is lost entirely
(Fig. 5D). Mutation of the middle site also results in ablation of
binding (Fig. 5E). This could mean that the middle binding site
is obligatory, or it may indicate that the distance between the
two flanking sites is too great for the GTF2IRD1 protein to
span. To discriminate between these possibilities, a series of
probes were made with progressive 8-bp deletions within the
middle region (Fig. 5G), which showed that binding is restored
once the distance between the flanking sites is reduced to 57 bp
and becomes progressively stronger as the distance narrows
(Fig. 5F).
The GUR Is an Effective Promoter/Enhancer That Can Be
Repressed by GTF2IRD1—The next step was to examine
whether the GUR has promoter/enhancer capabilities and to
determine whether GTF2IRD1 binding can negatively regulate
this function. We amplified a 193-bp fragment containing the
GUR, which was inserted into a pGL3-luciferase reporter con-
struct. A fragment longer than the conserved 104-bp GUR was
used to take advantage of convenient internal restriction sites.
Constructs containing 3-bp mutations in the flanking
GGATTA binding sites were also made to determine the con-
sequences of reduced DNA binding capability, as shown in the
EMSA studies. These reporter constructs were transiently
transfected into a C2C12 cell clone (C2GI) that contained an
inducibleMyc-GTF2IRD1 construct (Fig. 6,A andB). Inducible
expression of the tagged protein allowed low level expression in
a high proportion of cells (50%), which could be monitored
using immunofluorescence (Fig. 6A). The mouse C2C12 myo-
blast cell line was chosen because endogenous Gtf2ird1 tran-
script, and protein is abundant in these cells (Figs. 6B and 1C),
so it was assumed that these cells would have the appropriate
factors necessary for GUR activation.
Transfection of pGL3-GUR, containing thewild-type 193-bp
GUR fragment, led to levels of luciferase activity 50-fold greater
than the parental plasmid (Fig. 6, C and D), which contains no
promoter or enhancer. However, luciferase levels were 10-
fold lower than those produced by the transfection of the pGL3-
Control plasmid, which contains a strong SV40 viral promoter
and enhancer (data not shown). Induction of the exogenous
Myc-GTF2IRD1 by the addition of the RheoSwitch ligand
(RSL) resulted in a 70% reduction in luciferase activity in cells
transfected with pGL3-GUR (Fig. 6C) but had no effect on the
expression of the control SV40-luciferase reporter (data not
shown). The induction ligand RSL had no independent effect
on luciferase levels in parental C2C12 cells transfected with the
GUR-luciferase reporters (Fig. 6D). Reporter constructs with
mutant GGATTA binding sites showed reduced efficiency of
GTF2IRD1 repression. The construct with both flanking sites
mutated showed a repression of only 30% (Fig. 6C), thus sup-
porting the findings of the DNA binding studies in the link
between the interaction of the protein and its target sequence.
DISCUSSION
In this study, we have shown that the gene GTF2IRD1 is
subject to negative autoregulation using a mechanism that
involves direct binding of the GTF2IRD1 protein to a highly
conserved region (GUR) within the GTF2IRD1 locus. The
nature of the binding interaction is unusual, in that it involves
the simultaneous binding of at least two separate DNA binding
domains to a minimum of two identical GGATTA recognition
sequences.
Consequences of Gtf2ird1Mutation in theMouse—Anumber
of mutations of the mouse Gtf2ird1 locus now exist and differ-
ences in phenotypes are emerging. The KO we have generated
involves the targeted deletion of exon 2, which results in the
efficient production of a 1–3 spliced mutant transcript that
escapes NMD. Translation of an N-terminal truncated form of
GTF2IRD1 from this mutant transcript occurs with an esti-
mated efficiency of 3%. Because levels of transcript in KOmice
are approximately double wild-type levels, we estimate that the
truncated peptide is present at 6% of normal GTF2IRD1 pro-
tein levels. The phenotypic consequences of this mutation
appear to be very similar to another KO line, in which exons
2–5 are deleted (22), and the Gtf2ird1tm2(LacZ)Hrd mutant line,
in which LacZ has been inserted into exon 2 (20). Homozygous
null mice from these lines do not have major developmental
abnormalities, but show defects in brain function and behav-
ioral alterations (22).5
The random insertion of a c-myc transgene led to the pro-
duction of another Gtf2ird1 mutant mouse line (Tg(Alb1-
Myc)166.8), due to a 40-kb deletion removing exon 1 and the
Gtf2ird1 promoter (23). Homozygous nullmice of this line have
amild craniofacial abnormality (24) and increased brain ventri-
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FIGURE 5. EMSA of GTF2IRD1 proteins showing affinity for the GUR and the tandem nature of the binding. A, binding of human GTF2IRD1 to synthetic
multimers of the TNNI1-derived probe, B1, originally used as a yeast one-hybrid bait (10). GTF2IRD1 (IRD1) does not bind detectably to single copies, but binds
well to B1 dimers (2xB1) and trimers (3xB1). A lower shift complex (LC) is present in both, but a higher shift complex (HC) appears with the trimer. Probes
combined with unprogrammed in vitro translation mix (IVT) or with GTF2IRD1 and excess cold competitor oligonucleotide (COLD) showed no shift. An
unknown endogenous shift complex (arrows) present in the in vitro translation mix shows only a minor affinity increase as a result of multimerization. B, GUR
fragment is bound efficiently by the twomost abundantmouse isoforms of GTF2IRD1, 37, and 35 and by humanGTF2IRD1, but not by themouse isoform
of TFII-I (GTF2I). No shift occurs in the IVT control or probe-only lane (PR). C, deletion of the leucine zipper domain of GTF2IRD1 (IRD1LZ) intensifies affinity of
the LC, but ablates the HC, demonstrating that the HC contains a GTF2IRD1 dimer. D and E, probes containing mutations in single GGATTA sites or in
combinations were testedwith human GTF2IRD1 protein to determine changes in affinity. Position of themutation (M) is indicated on the scheme of the GUR
(arrows). F, mutation of the middle site alone leads to absence of binding, but the shifts are restored by reducing the distance between the flanking sites, as
illustrated using a series of probes with successive deletions (GURDEL1–5). G, sequences of the double-stranded probes used in the EMSA: binding sites are
indicated in bold type, andmutations are indicated in lowercase bold type. In theGURDEL series, the residues deleted in each successive probe are indicated by
underlines. Gaps between images indicate where irrelevant lanes have been removed.
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cle volume (25) but exhaustive behavioral testing was not done.
Craniofacial abnormalities have not been observed in the tar-
geted gene KOs, and it is possible that the phenotypic differ-
ences are because of genetic background or additional effects
on genes adjacent to Gtf2ird1 in the (Tg(Alb1-Myc)166.8)
transgenic line due to a disruption of gene regulation resulting
from the large 40-kb deletion.
A gene trap mutant was recently reported in which a LacZ-
neomycin fusion cassette had inserted into intron 22 of the
Gtf2ird1 locus (26). In contrast to the other studies, homozy-
gosity for this mutation was embryonic lethal. The authors
argue that alternative splicing and alternative promoter usage
ensures the survival of some GTF2IRD1 protein in other
Gtf2ird1 mutant lines, thus explaining the less severe pheno-
type. This explanation is unlikely as transcription of Gtf2ird1
in the (Tg(Alb1-Myc)166.8) mutants was undetectable (24),
and analysis of the mutant transcript produced in the
Gtf2ird1tm1Hrd mice reported here indicate very low levels of
protein synthesis. All of the reported splice isoforms and (puta-
tive) alternative promoter-driven transcripts (18, 27) include
exons 2 and 3, and would, therefore, be subject to the same
translation constraints as the 37 isoform used in the above
analysis. Therefore, our estimate of 6% total protein synthesis in
homozygousGtf2ird1tm1Hrdmice applies, regardless of alterna-
tive splicing possibilities. It is hard to imagine how such a small
amount of residual protein is sufficient to explain these signif-
icant phenotypic differences. Furthermore, the exon 1 alterna-
tives 1a and 1b (27), and themuchmore frequently used exon 1,
all cluster together within the same 1-kb region of the genome,
which would suggest that all transcripts fall under the same
regulatory constraints, even if there is some wobble around the
transcription start site.
An alternative explanation for the phenotypic difference
arises from the fact that the gene-trap strategy does not prevent
GTF2IRD1 protein synthesis, but creates a peptide fusion
betweenmost of theN-terminal region ofGTF2IRD1 (72%) and
-GEO. This fusion protein might retain sufficient GTF2IRD1
peptide to permit interaction with its usual protein partners or
DNA targets but the presence of the additional peptide attach-
ment may severely disrupt normal function. This dominant-
negative explanation predicts that heterozygous mutants
would have more severe consequences than a hemizygous
Gtf2ird1 deletion. This does appear to be the case, as some of
the gene-trap mutants show more severe abnormalities than
another recently reported mouse line in which 7 contiguous
genes including Gtf2ird1 are hemizygously deleted (28).
Analysis of GTF2IRD1 Autoregulation in WBS Patients—
Analysis ofGTF2IRD1 transcript levels inWBSpatients is obvi-
ously hampered by access to suitable tissue samples. Therefore,
most analyses have focused on lymphoblastoid cell lines
derived from blood. The results presented here are supported
by several other studies (29–31) showing thatGTF2IRD1 tran-
script levels are not significantly different from controls,
whereas transcription levels from the flanking genes CYLN2
and GTF2I were 50% of normal, as expected.
In all studies, GTF2IRD1 transcript levels were highly vari-
able betweenWBS patients and between the controls, suggest-
ing that this is typical behavior and not related to the WBS
FIGURE 6. The GUR acts as an effective enhancer/promoter in cell culture
assays and is negatively regulated by exogenously derived inducible
GTF2IRD1. A, inducible Myc-GTF2IRD1 clonal cell line C2GI, with nuclei
stained by DAPI and Myc-tagged GTF2IRD1 detected by anti-Myc immuno-
fluorescence (Myc). B, Northern blot of C2GI and parental C2C12 (C2) cell RNA
with or without the inducer RSL. C, C2GI inducible GTF2IRD1 cells with pGL3-
Basic and pGL3-GUR constructs containing the wild-type GUR or with muta-
tions (M) in the flanking recognition sites. Induction of GTF2IRD1 leads to a
repression of the reporter containing the wild-type GUR. Mutations in the
GTF2IRD1 binding sites result in attenuation of repression. Luciferase activity
was set at 1 for the wild-type GUR, andmeasurements were normalized rela-
tive to this to combine experiments. Error bars indicate the S.D. of duplicate
measurements in two separate experiments. D, C2C12 parental cell line con-
trol experiment showing that repression is not causedby the induction ligand
RSL. A single experiment conducted in duplicate. Error bars indicate range.
E, diagram of reporter constructs used in C and D. The wild-type GUR and
permutations containing 3-bp mutations (M) in the GGATTA site were intro-
duced into pGL3-Basic in the appropriate orientation.
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deletion. However, the evidence for autoregulation in lympho-
blastoid cells is, nevertheless, compelling. The degree to which
the autoregulation is effective in restoring normal expression
levels of GTF2IRD1 protein in the developing affected tissues
(e.g. brain) of WBS patients is unknown and would be ethically
impossible to ascertain. Therefore, a role for GTF2IRD1 in the
cause ofWBS due to a slight reduction in expression cannot be
ruled out. It might be argued that the autoregulatory mecha-
nism may not operate in all cell types and lymphoblastoid cells
are unrepresentative of tissues affected byWBS. In this regard,
one analysis showsGTF2IRD1 levels to be significantly reduced
in fibroblasts from WBS patients (30). These differences may
arise due to the very low levels of GTF2IRD1 expression that
would be expected in these cell types, by extrapolation from
expression analysis in themouse (20). All of the tissues tested in
themouse, which were chosen on the basis of moderate to high
levels ofGtf2ird1 expression (20), showed similar levels of auto-
regulation, including the brain. It seems unlikely that such a
mechanism, with strong evidence of conservation across all
vertebrates, would operate in all of the tissues of one organism
but selectively in another species.
Binding of GTF2IRD1 to the GUR—EMSA analysis using in
vitro translated human and mouse GTF2IRD1 proteins
revealed that all isoforms tested have the ability to bind to the
GUR. Furthermore, high affinity binding is dependent on
simultaneous interactions of the protein with at least two sep-
arate GGATTA recognition sequences. Reduction to a single
recognition site leads to loss of binding and separation of the
recognition sequences beyond 57 bp also ablates binding. These
data are consistent with a model in which the GTF2IRD1 pro-
tein interacts in a tandem fashion with dual recognition
sequences, and this can be further enhanced by dimeric inter-
actions when three binding sites are present (Fig. 7). However,
this model may be oversimplistic as it must be noted that the
HC also appears when only two sites are present in the GUR
DEL series of probes. This may indicate that DNA sequence
outside of the GGATTA core can also influence the conforma-
tion of the interaction.
Deletion studies and purification of GST fusion peptides has
shown that the DNA binding functions of GTF2IRD1 are local-
ized within the repeat domains (RDs). These studies indicate
that RD2, 3, 4, and 5 all have DNA binding properties although
RD3 lacks sequence specificity (14–16). RD4 has the greatest
individual affinity (16) so it is likely that the tandem interaction
involves RD4 and one other RD. The evidence presented shows
that the predominant human isoform of GTF2IRD1 (11)
readily forms homodimeric and monomeric interactions with
the GUR, whereas homodimeric interactions of the mouse iso-
forms (35 and 37) are virtually undetectable. The ability to
form dimers could be influenced by sequence outside of the
well-conserved leucine zipper domain or RDs. Alternatively,
the addition of a sixth RD in rodent species has altered the
protein conformation and reduced this capacity. Extending the
comparison of binding to GTF2IRD1 from Xenopus and fish
species, or examination of mouse splice isoforms that contain 5
RDs would address this question.
GTF2IRD1 has been isolated in four separate yeast one-hy-
brid studies (10–13) and the bait DNA sequence, containing a
single GGATTA, was triplicated in all of them, which is a com-
mon strategy tomaximize the chance of trapping potential prey
proteins. On the basis of work presented here, it is likely that
these baits created an artificial selection bias for GTF2IRD1,
which shows vastly increased affinity for multiple binding sites.
Whereasmost studies have concluded that GTF2IRD1 acts as a
transcriptional regulator of specific gene targets, future studies
should now address whether the affinity of GTF2IRD1 for the
single GGATTA site present in the proposed targets, TNNI1
(10, 11),GSC (13), orHoxc8 (12) is sufficient to be of biological
importance.
Evolutionary Considerations—It is worth considering why
the GTF2IRD1 feedback mechanism exists and why it has been
so faithfully conserved in vertebrates. It cannot have evolved as
a dosage compensation mechanism as there would be no
requirement under normal circumstances. It might act as a
homeostaticmechanism thatmaintainsGTF2IRD1 protein at a
set level. However, this would have to be context dependent as
transcript levels vary considerably between cell types (20). Fur-
thermore, modeling studies suggest that strong negative auto-
regulatory circuits increase noise rather than reducing it (32),
and thismight explain why transcript levels ofGTF2IRD1 show
high variability.
Alternatively, negative autoregulation circuits can dramati-
cally enhance protein synthesis rise-time to steady state levels
(33), and this could provide cells with much greater control
over temporal expression. The kinetic behavior of genes
involved in transcriptional regulation is an important consider-
ation for the understanding of regulatory gene networks and
this may prove to be an essential part of GTF2IRD1 function.
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SUPPLEMENTARY DATA 
 
 
 
 Patient Cell Lines Relative Cell Lines 
Pair # Repository # Sex Age Repository # Relation  Age 
1 GM14162 M  28 GM14163 Mother 55 
2 GM14171 M  38 GM14173 Father 68 
3 GM14182 M  22 GM14183 Father 55 
4 GM14268 F 19 GM14267 Mother 49 
5 GM14291 F 11 GM14292 Mother 39 
6 GM14297 F 32 GM14295 Mother 62 
 
Supplementary Table S1. 
Coriell Cell Repository Cell lines 
Cell line repository number (#), sex and age of the patients from which the lymphoblastoid cell lines were derived. The Pair number (#) 
corresponds to the pairing shown on the graphs (Fig. 3 and Fig. S1). Full details of the cell lines and the patients from which they are derived is 
available at http://ccr.coriell.org 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table S2 
Names and sequence of 
the oligonucleotides 
synthesised for all 
experiments. 
Bold type indicates the 
position and sequence of 
the mutant residues. 
Name Sequence 
mIRD1ex1F CCAGAGGCGACTGGATCTAC 
mIRD1ex3R ACGAAGACGCTCTCATTGTG 
mIRD1ex6F TACAGCACTTCGATGCCCAACCAC 
mIRD1ex7/8R GATCCCACTTCTCTGACTTGTCATG 
mHPRTF AGCTTGCTGGTGAAAAGGAC 
mHPRTR TCAACTTGCGCTCATCTTAG 
hCYLN2F AAATCCCTGTCGGATCAGAG 
hCYLN2R TTTGCAGAACCGGAATTGCC 
hGTF2IF CTGGAAATCAGCTCCATGAG 
hGTF2IR GATCTGAGAGCTTCCATCAG 
hIRD1ex21F TGGAGAGGATTCTTGCTGTG 
hIRD1ex23R CCTCACCGTATTTCTCGTTG 
hIRD1ex25F GGCTGGAGAAGATCCTGAAG 
hIRD1ex27R ATGCTGCTGTCTTTGGCTGG 
hGAPDHF CCATGTTCGTCATGGGTGTG 
hGAPDHR CATCCACAGTCTTCTGGGTG 
hIRD1LZdel TTAAGCTTACCATGGACTTCCTCAGGTTCTGCCG 
GURF TGCGGGCTAATCCCGTATGTAAATG 
GURF MUT TGCGGGCTTGACCCGTATGTAAATG 
GURR TTTGTTCTGTAATCCCAGTAAGATTG 
GURR MUT TTTGTTCTGTTGACCCAGTAAGATTG 
GUR MID 
MUT 
TGCGGGCTAATCCCGTATGTAAATGACAGCCAATGGAGGGTGGTGTTGCGCGGGGC
TGGGTCAAGGGCCGGGGCGAATGGCTGGCAATCTTACTGGGATTACAGAACAAA 
GUR LUC F GAGTCTCGAGGCTCCGAGGTTG 
GUR LUC R GCGAGCGCGAAGCCGAGCCCG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure S1  
A second analysis of GTF2IRD1 expression in lymphoblastoid cell lines. 
Quantitative RT-PCR analysis of GTF2IRD1 expression in lymphoblastoid cell lines derived from WBS patients and their relatives (see Table 
S1) using the primers Ex25F – Ex27R (see Table S2). Magenta bars represent the relative samples and blue bars represent patient samples. Error 
bars show standard deviations.  
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